ArticleChest2025
Sputum Cellularity and MRI Ventilation Defects in Severe Asthma.
Article in Chest, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Computed tomography-derived pulmonary blood volume distribution may be modifiable in asthma.ERJ open research · 2026Article
- Disease Classification of Pulmonary Xenon Ventilation MRI Using Artificial Intelligence.Academic radiology · 2025Article
- Innovating the Gold Standard: The Emerging Role of Echocardiographic Stress Testing in the Classification, Stratification, and Prognostication in Pulmonary Vascular Disease.Current cardiology reports · 2025Review
- New insights into mesenchymal stem cells in inflammatory subtypes of asthma.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAirway inflammation is a hallmark feature of asthma characterized by elevated eosinophils and/or neutrophils. Eosinophils in sputum can contribute to ventilation defects. The functional consequence of other types of cellularity on ventilation is unknown. RESEARCH QUESTION: What is the effect of different sputum cellular phenotypes on abnormal ventilation evaluated by STUDY DESIGN AND
methodsEighty-five patients with severe asthma and 15 healthy control participants underwent
resultsIn patients with asthma, ventilation was abnormal (MRI VDP above the upper limit of normal) for 44% (14 of 32) of those with paucigranulocytic sputum, 64% (14 of 22) with eosinophilic bronchitis, 75% (9 of 12) with neutrophilic bronchitis, and 89% (17 of 19) with mixed-granulocytic bronchitis. Compared to healthy control participants, MRI VDP was higher in participants with asthma with eosinophilic (adjusted P = .0002), neutrophilic (adjusted P = .0001), and mixed-granulocytic phenotypes (adjusted P < .0001) but not a paucigranulocytic phenotype (adjusted P = .051). Among participants with paucigranulocytic asthma, those with an MRI VDP above the upper limit of normal were older (P = .006), had higher fractional exhaled nitric oxide (P = .02), and higher CT mucus scores (P < .0001).
interpretationOur results indicate that in severe asthma, ventilation is abnormal in the presence of intraluminal cellular inflammation, irrespective of phenotype. Abnormal ventilation in paucigranulocytic asthma may be due to airway mucus and was shown to often be associated with elevated fractional exhaled nitric oxide.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.